[
    {
        "id": "osp-2444",
        "type": "article-journal",
        "title": "Respiratory Complications after COVID-19",
        "author": [
            {
                "family": "Al Jahdhami",
                "given": "Issa"
            },
            {
                "family": "Al-Naamani",
                "given": "Khalid"
            },
            {
                "family": "Al-Mawali",
                "given": "Adhra"
            },
            {
                "family": "Bennji",
                "given": "Sami M."
            }
        ],
        "URL": "https://omanscience.com/en/articles/respiratory-complications-after-covid-19",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2022
                ]
            ]
        },
        "container-title": "Oman Medical Journal",
        "DOI": "10.5001/omj.2022.52",
        "publisher": "Oman Medical Specialty Board",
        "ISSN": "1999-768X",
        "abstract": "COVID-19 pandemic has been associated with high short-term morbidity and mortality. Lungs are the main organs affected by SARS-CoV-2 infection. In the long-term, the pulmonary sequelae related to COVID-19 are expected to rise significantly leading to an extended impact on community health and health care facilities. A wide variety of long-term respiratory complications secondary to COVID-19 have been described ranging from persistent symptoms and radiologically observable changes to impaired respiratory physiology, vascular complications, and pulmonary fibrosis. Even after two-years, respiratory sequalae related to post-acute SARS-CoV-2 infection have not been fully explored and understood. The main treatment for most COVID-19 respiratory complications is still symptomatic and supportive-care oriented. In this review article, we shed light on current knowledge of the post-COVID-19 complications, focusing on pulmonary fibrosis, treatment directions, and recommendations to physicians."
    }
]